GlassScriptPhysician profile
Danny Issa
NPI 1750631396
$187,844.90
in general payments reported to CMS, 2019-2025
13 companies · $116K in 2025
The $116K reported for 2025 was more than what 99% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $166 · 2021: $333 · 2022: $647 · 2023: $920 · 2024: $45K · 2025: $116K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $128K · Travel and Lodging: $18K · Consulting Fee: $9,365 · Food and Beverage: $5,706 · Education: $89.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $128,000.00 |
| Travel and Lodging | $18,053.67 |
| Consulting Fee | $9,365.00 |
| Food and Beverage | $5,705.93 |
| Education | $89.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $140,120.65 | 2024-2025 | Zepbound |
| Boston Scientific Corporation | $42,998.40 | 2019-2025 | Orise, Apollo Esg System, Exalt Model D |
| Cook Incorporated | $2,790.00 | 2025 | Hemospray |
| Cook Medical LLC | $782.70 | 2023-2025 | Hemospray, Echotip Insight, Fusion |
| Olympus America INC. | $322.70 | 2019-2020 | |
| Apollo Endosurgery US INC | $239.61 | 2021-2022 | |
| Conmed Corporation | $190.73 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $100.05 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.96 | 2024 | Xifaxan |
| Janssen Biotech, INC. | $89.00 | 2025 | Tremfya |
| Olympus Corporation of The Americas | $83.52 | 2025 | Single Use Aspiration Needle Na-U200h |
| Abbvie INC. | $15.98 | 2019 | |
| Shire North American Group INC | $11.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Issa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.